Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1999 1
2004 1
2005 1
2006 1
2008 2
2009 2
2010 1
2012 2
2013 2
2014 8
2015 9
2016 5
2017 2
2018 2
2019 6
2020 9
2021 8
2022 15
2023 16
2024 15
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Home blood pressure monitoring devices: what extra value do they bring?
Divisón-Garrote JA, Juárez Gonzálvez P, Turégano-Yedro M, Pallarés-Carratalá V. Divisón-Garrote JA, et al. Among authors: pallares carratala v. Expert Rev Med Devices. 2024 Jul;21(7):555-557. doi: 10.1080/17434440.2024.2375374. Epub 2024 Jul 3. Expert Rev Med Devices. 2024. PMID: 38953835 No abstract available.
[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].
Pallarés-Carratalá V, Polo García J, Martín Rioboo E, Ruíz García A, Serrano-Cumplido A, Barrios V; en nombre del Grupo de trabajo de Hipertensión y Enfermedad Cardiovascular de SEMERGEN. Pallarés-Carratalá V, et al. Semergen. 2021 Jan-Feb;47(1):1-3. doi: 10.1016/j.semerg.2020.12.005. Epub 2021 Jan 2. Semergen. 2021. PMID: 33478841 Free PMC article. Spanish. No abstract available.
Home blood pressure self-measurement: "Current situation and new perspectives".
Divisón-Garrote JA, Velilla-Zancada S, Artigao-Rodenas LM, García-Lerín A, Vicente-Molinero A, Piera Carbonell AM, Alonso-Moreno FJ, Crespo-Sabarís R, Valls-Roca F, Martín-Rioboó E, Pallarés-Carratala V. Divisón-Garrote JA, et al. Among authors: pallares carratala v. Hipertens Riesgo Vasc. 2023 Apr-Jun;40(2):85-97. doi: 10.1016/j.hipert.2022.07.005. Epub 2022 Sep 13. Hipertens Riesgo Vasc. 2023. PMID: 36114104 Review.
[Metabolic treatment of ischemic cardiopathy].
Morillas Blasco PJ, Hernándiz Martínez A, Pallarés Carratalá V, Portolés Sanz M, Cosín Aguilar J. Morillas Blasco PJ, et al. Among authors: pallares carratala v. Rev Clin Esp. 2004 Feb;204(2):109-18. doi: 10.1157/13058809. Rev Clin Esp. 2004. PMID: 15023313 Review. Spanish. No abstract available.
Multidisciplinary management of cardiovascular disease in women: Delphi consensus.
Gámez JM, Pedreira Pérez M, Fernández Olmo MR, Fasero Laiz M, Inaraja V, Pallarés Carratalá V. Gámez JM, et al. Among authors: pallares carratala v. Front Cardiovasc Med. 2024 Feb 21;11:1315503. doi: 10.3389/fcvm.2024.1315503. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38450371 Free PMC article.
[Dyslipidaemia and vascular risk. A new evidence based review].
Pallarés-Carratalá V, Pascual-Fuster V, Godoy-Rocatí D. Pallarés-Carratalá V, et al. Semergen. 2015 Nov-Dec;41(8):435-45. doi: 10.1016/j.semerg.2014.10.015. Epub 2015 Jan 2. Semergen. 2015. PMID: 25559484 Review. Spanish.
Overview of guidelines for the management of dyslipidemia: EU perspectives.
Giner-Galvañ V, Esteban-Giner MJ, Pallarés-Carratalá V. Giner-Galvañ V, et al. Among authors: pallares carratala v. Vasc Health Risk Manag. 2016 Sep 6;12:357-369. doi: 10.2147/VHRM.S89038. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27660458 Free PMC article. Review.
95 results